trastuzumab-anns 150 MG Injection [Kanjinti]

RxNorm concept 2257300, branded drug (sbd). Prescribable name: KANJINTI 150 MG Injection.

RxCUI: 2257300
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2257300 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

trastuzumab 224905

Other names

Kanjinti 150 MG Injection

Related concepts

trastuzumab-anns 150 MG (SCDC, consists of)
trastuzumab-anns 150 MG [Kanjinti] (SBDC, consists of)
Injection (DF, has dose form)
Kanjinti (BN, has ingredient)
trastuzumab-anns 150 MG Injection (SCD, tradename of)

Linked data

NDCs

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 2257300 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2257300 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2257300. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.